A fermentation technology that replaces animal-derived peptone with soy-based peptone to produce postbiotics from lactic acid bacteria (LAB Streptococcus). This approach enables oral supplement manufacturers to meet Halal and Kosher certification requirements while maintaining scalable production yields.
This research addresses a critical formulation challenge in the postbiotics and oral supplement industry: producing lactic acid bacteria (LAB) derived postbiotics that comply with Halal and Kosher dietary requirements. Traditional fermentation processes rely on animal-derived peptone, which creates certification barriers for products targeting Muslim and Jewish consumer markets. The proposed solution replaces animal-based peptone with plant-based soy peptone, enabling manufacturers to access these significant market segments without compromising production viability.
The technology is particularly valuable for nutraceutical, functional food, and dietary supplement companies seeking to develop certified-compliant postbiotic formulations. By adapting fermentation conditions and medium composition, the process achieves scalable yields suitable for commercial production.
Key features:
The fermentation workflow follows a systematic approach: medium preparation with soy peptone, inoculation with LAB Streptococcus, controlled fermentation with step-by-step monitoring, and final yield assessment through both predictive modeling and laboratory validation.
The technology is currently at an early-to-mid development stage. Initial laboratory assessments have demonstrated that the plant-based medium can produce postbiotic yields comparable to traditional animal-based fermentation, though optimization is ongoing. Response Surface Methodology (RSM) has been performed to model and optimize production parameters, with in vitro fermentation validation planned or underway. Each fermentation step is being monitored through visual observation, microscopy, 16S rDNA analysis, and metabolite profiling to ensure product quality and consistency. Further refinement of medium composition and growth conditions is expected to improve yields toward optimal commercial levels.
Universitas Indonesia (UI) is a large public research university with more than 40,000 active students and a comprehensive academic profile, operating across its main campus in Depok and Salemba campus in Jakarta. Its 320-hectare Depok campus supports shared laboratories, research facilities, and industry engagement in the Jakarta metropolitan region. The Science Techno Park and Integrated Laboratory and Research Center provide platforms for industry partnership, technology transfer, and startup incubation, while UI’s Academic Health System links health faculties with eight teaching and partner hospitals. Research draws on competitive support from Indonesia’s Ministry of Higher Education, Science and Technology, BRIN, and LPDP.